NNBP

Nanobac Pharmaceuticals, Incorporated Stock Price

OTCPK:NNBP Community·US$249.0 Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NNBP Share Price Performance

US$0.000001
0.00 (0.00%)
US$0.000001
0.00 (0.00%)
Price US$0.000001

NNBP Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Nanobac Pharmaceuticals, Incorporated Key Details

US$17.6k

Revenue

US$14.5k

Cost of Revenue

US$3.1k

Gross Profit

US$6.6m

Other Expenses

-US$6.6m

Earnings

Last Reported Earnings
Dec 31, 2007
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About NNBP

Founded
1994
Employees
n/a
CEO
John Stanton
Website
n/a

Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles (CNPs). It manufactures and markets in vitro diagnostic (IVD) kits, such as assays, antibodies, and reagents for detecting CNPs. The company’s diagnostic assays comprise NANO-CAPTURE and NANO-SERO. Additionally, it conducts research and clinical studies in the development of urological diseases, including chronic prostatitis/chronic pelvic pain syndrome, kidney stones, and polycystic kidney diseases, as well as cardiovascular diseases. Nanobac Pharmaceuticals, Incorporated was formerly known as HealthCentrics Inc. and changed its name to Nanobac Pharmaceuticals, Incorporated in December 2002. The company was founded in 1994 and is based in Tampa, Florida.

Recent NNBP News & Updates

Recent updates

No updates